Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

Successful cancer control relies on overcoming resistance to cell death and on activation of host antitumor immunity. Oncolytic viruses are particularly attractive in this regard, as they lyse infected tumor cells and trigger robust immune responses during the infection. However, repeated injections...

Descripción completa

Detalles Bibliográficos
Autores principales: Vähä-Koskela, Markus, Tähtinen, Siri, Grönberg-Vähä-Koskela, Susanna, Taipale, Kristian, Saha, Dipongkor, Merisalo-Soikkeli, Maiju, Ahonen, Marko, Rouvinen-Lagerström, Noora, Hirvinen, Mari, Veckman, Ville, Matikainen, Sampsa, Zhao, Fang, Pakarinen, Päivi, Salo, Jarmo, Kanerva, Anna, Cerullo, Vincenzo, Hemminki, Akseli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782942/
https://www.ncbi.nlm.nih.gov/pubmed/27119097
http://dx.doi.org/10.1038/mto.2014.6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782942/
https://www.ncbi.nlm.nih.gov/pubmed/27119097
http://dx.doi.org/10.1038/mto.2014.6

Ejemplares similares